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INSIGHTS

In this issue, two independent groups show that the transcription factor ZBTB20 is required for the maintenance of long-lived plasma cells following immunization with the commonly used adjuvant, alum. Intriguingly, one group found that ZBTB20 was dispensable for plasma cell survival when they used adjuvants
that activate Toll-like receptors (TLRs).
Protection from recurrent infections depends on long-lived plasma cells secreting high-affinity antibodies,
which are generated during T cell–dependent immune responses in the germinal center reaction. But not all
vaccinations or infections yield durable and protective plasma cell responses. Therefore, a better understanding
Insight from
of the molecular mechanisms that govern plasma cell generation and maintenance is needed in order to
Ulf Klein
develop more effective vaccines.
Chevrier et al. and Wang and Bhattacharya now show that the BTB-POZ transcription factor ZBTB20,
which is expressed in germinal center B cells and at high levels in plasma cells, is crucial for maintaining durable antibody
responses by promoting cell survival following immunization of mice with a model antigen in alum. But when Wang and
Bhattacharya administered the same antigen with TLR-ligand based adjuvants they observed that ZBTB20 was dispensable for
the development and survival of plasma cells. Both ZBTB20-dependent and -independent plasma cell survival pathways were
B cell–intrinsic, suggesting that the immune cells activated by the corresponding adjuvants imprint longevity on the plasma cells
when they are formed within the germinal centers.
The mechanisms underlying this imprinting process are presently unknown and require further investigation. Chevrier
et al. show clearly that the control of ZBTB20 expression differs fundamentally between germinal center B cells and plasma cells.
Zbtb20 is a transcriptional target of the
plasma cell master regulator IRF4 in plasma
cells, but not in the majority of germinal
center B cells, which lack IRF4. However,
IRF4 expression is up-regulated in a small
subset of late germinal center B cells that are
plasma cell precursors. It is therefore possible that the ZBTB20-dependent survival
program is initiated at this developmental
stage through interaction with T follicular
helper cells. Similarly, this particular germinal center subpopulation may be the
downstream target of TLR-ligand based
adjuvants. It will be important to identify
the ZBTB20-equivalent transcription factor, which Wang and Bhattacharya suggest
might be another BTB-POZ transcription
factor, ZBTB32.
An important implication of the current studies is that we need to dissect the
transcription factor network that controls
plasma cell generation within the germinal
center in order to understand how adjuModel of how different adjuvants may imprint distinct plasma cell survival programs
vants improve the durability of vaccines.
in late germinal center B cells.
In addition, the results clearly indicate that
in vaccine development, it is important to
know whether an infection triggers an alum-like or TLR-biased response. The findings also serve as a reminder to be more cautious
with generalizing results obtained from the study of a single immunization model.
Chevrier, S., et al. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20131831.
Wang,Y., and D. Bhattacharya. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20131821.
Ulf Klein, Columbia University: uk30@columbia.edu
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Lymphatics help baby take first breath

absorbed lung fluid during preparation for birth; the newborn mice then fail to inflate
their lungs and can’t breathe.

Jakus, Z., et al. 2014. J. Exp. Med. http://dx.doi
.org/10.1084/jem.20132308.
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Using mutant mice that lack lymph vessels, Jakus et al. show that prenatal lymphatic function is required for
neonatal lung inflation and respiration.
In the womb, a baby’s lungs are filled with fluid that must be cleared close to birth to allow neonatal lung
inflation and respiration. The bulk of the fluid is cleared by active transepithelial absorption from the airways
into the lung interstitial spaces, a process that starts before birth in response to hormonal changes.
Jakus et al. observed that in mice that lack the gene encoding CCBE1 or that express a dysfunctional
VEGFR3 receptor, molecules involved in lymph vessel formation, the majority of the newborn pups
are bluish in color and do not start to breathe. Although the lungs develop and mature normally, they fail to Insight from
Mieke Dewerchin
inflate and the mice die shortly after birth.
In healthy wild-type late-gestation embryos, the authors found that pulmonary lymphatics are already
functioning. But in the mutant embryos, the absence of lymphatic function was associated with accumulation of fluid in the
lung tissue and with reduced ability of the prenatal lung to expand (a feature known as lung compliance). Based on these
observations, Jakus et al. propose a model
in which pulmonary lymphatic function
in preterm mice is required for drainage of
absorbed fluid in the lungs, thus preventing
tissue edema and securing intrinsic lung
compliance prior to birth. In this way, prenatal
lymphatic function helps prepare the lungs
for inflation and gas exchange after birth.
It was reported previously that lymphatics contribute to the clearance of remaining
lung fluid in newborns and that lymphatic
hypoplasia compromises neonatal survival.
Jakus et al. extend these findings by revealing
the importance of functional pulmonary lymphatics prior to birth. Besides other crucial
mechanisms, such as surfactant production,
prenatal lymphatic function appears to be an
additional mechanism required to prepare
the lung for inflation, which is a previously
unrecognized role of the lymphatic system.
The authors observed differences in phenotype severity depending on the genetic
background of the mutant mice, suggesting
the influence of as yet unidentified modifying factors. Nevertheless, further investigation
into temporal aspects of prenatal lymphatic
drainage may elucidate whether inadequate
prenatal lymphatic function contributes to
respiratory distress syndrome in premature
infants, and may explain respiratory failure
in infants with congenital pulmonary lymphangiectasia, a rare disorder of lung lymphatic development.
Lungs of prenatal mice lacking lymphatics display impaired drainage of interstitially
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O’Donovan, K.J., et al. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20131780.
Valeria Cavalli and David M. Holtzman, Washington University School of Medicine in Saint Louis: cavalli@pcg.wustl.edu and holtzman@neuro.wustl.edu

New role identified for LRR-containing proteins
in T cell development
There are thousands of leucine-rich repeat (LRR)–containing proteins, which share a common structural
horseshoe-shaped motif but have distinct and unrelated functions. Among the LRR-containing proteins
involved in the immune system, Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain
(NOD)–like receptor proteins (NLRPs) easily come to mind, with important functions in pathogen recognition
by innate immune cells. Nevertheless, there are many other LRR-containing proteins whose functions
remain to be fully elucidated.
In this issue, Kumar et al. report their work on the role of LRRC8A in lymphocyte development and
function. The current study was initiated following identification of a translocation mutation in the LRRcontaining 8A (LRRC8A) gene in a patient with no B cells and agammaglobulinemia, which resulted in a
truncated protein that severely inhibited B cell development and function. However, the function of LRRC8A
in lymphocytes or its role in other cell lineages is not fully understood.
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The mechanisms that drive axon regeneration after central nervous system (CNS) injury or
disease are proposed to recapitulate, at least in part, the developmental axon growth pathways.
This hypothesis is bolstered by a new study by O’Donovan et al. showing that activation of
a B-RAF kinase signaling pathway is sufficient to promote robust axon growth not only during
development but also after injury.
B-RAF was previously shown to be essential for developmental axon growth but it was
not known if additional signaling pathways are required. In this study, the authors demonstrate that activation of B-RAF alone is sufficient to promote sensory axon growth during
Insight from Valeria Cavalli (left)
development. Using a conditional B-RAF
and David Holtzman
gain-of-function mouse model, the authors
elegantly prove that B-RAF has a cell-autonomous role in the developmental
axon growth program. Notably, activated B-RAF promoted overgrowth of
embryonic sensory axons projecting centrally in the spinal cord, suggesting
that this pathway may normally be quiescent in central axons.
Could activated B-RAF also enhance axon regeneration in the adult
central nervous system? The authors found that activated B-RAF not only
enabled sensory axon growth into the spinal cord after spinal injury, but also
promoted regrowth of axons projecting in the optic nerve. Regeneration in
the injured CNS is prevented by both the poor intrinsic regrowth capacity
of axons and by inhibitory factors in the tissue environment. Importantly,
the B-RAF–activated signaling growth program was insensitive to this
repulsive environment.
Interestingly, the authors find that B-RAF synergizes with the PI3Activation of B-RAF signaling enables crushed
kinase–mTOR pathway, which also functions downstream of growth factors.
sensory axons (green) to grow into the adult
This opens the possibility that combinatorial approaches that integrate these
spinal cord in both white (white arrows) and gray
(pink arrows) matter.
two pathways may heighten regenerative capacity.
This in vivo study significantly advances the understanding of the role
of MAP kinases in axon growth and suggests that reactivation of the B-RAF pathway may be exploited to promote axon
regeneration in the injured central nervous system. An exciting future avenue will be to determine the downstream mechanisms
controlled by B-RAF.
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Thymi from Lrrc8a-/- mice showed a threefold
reduction in the numbers of double-negative,
double-positive, and single-positive thymocytes
compared with wild-type thymi.

The authors generated Lrrc8a-deficient mice that showed a defect in both
T cell development and function, with increased thymocyte apoptosis, but only
a mild defect in B cell development. LRRC8A, which is expressed on the cell
surface, appears to engage a ligand expressed on thymic epithelial cells, as well as
on multiple other stromal cells. The authors provide evidence that this interaction
leads to AKT activation via an LCK–ZAP-70–GAB2–PI3K signaling pathway in
T cells. However, further work will be required to definitively establish whether
the AKT signaling pathway is crucial for the defect in thymocyte development
observed in Lrrc8a-null mice. In addition to the defect in thymocyte survival
and proliferation, Lrrc8a-deficient mice also exhibited defective T cell function
downstream of the TCR. These findings were unexpected, as the initial
characterization of the human LRRC8A mutation had a more severe defect in
the development and function of B cells than T cells.This difference may be due
to a dominant-negative gain of function of the truncated mutation displaying
broader and distinct effects in humans compared with the effects observed in the
gene-deficient mice.
These exciting findings point to an as yet unappreciated role for LRRcontaining proteins in T cell development and function. It is likely that other
members of this large gene family may be equally important, and thus the present
report serves as a clarion call for further work on LRRC8A-related genes in
lymphocyte differentiation and function.

